These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38443729)

  • 21. Long non-coding RNA ANRIL down-regulates microRNA-7 to protect human trabecular meshwork cells in an experimental model for glaucoma.
    Zhao J; Sun H; Zhang JM; Wang M; Du XJ; Zhang JL
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3173-3182. PubMed ID: 31081068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of age- and gender-associated long noncoding RNAs in the human brain with Alzheimer's disease.
    Cao M; Li H; Zhao J; Cui J; Hu G
    Neurobiol Aging; 2019 Sep; 81():116-126. PubMed ID: 31280115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ANRIL and atherosclerosis.
    Chen L; Qu H; Guo M; Zhang Y; Cui Y; Yang Q; Bai R; Shi D
    J Clin Pharm Ther; 2020 Apr; 45(2):240-248. PubMed ID: 31703157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysregulation of LncRNA ANRIL mediated by miR-411-3p inhibits the malignant proliferation and tumor stem cell like property of multiple myeloma via hypoxia-inducible factor 1α.
    Wang M; Zhao HY; Zhang JL; Wan DM; Li YM; Jiang ZX
    Exp Cell Res; 2020 Nov; 396(1):112280. PubMed ID: 32961145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circular RNA and Alzheimer's Disease.
    Akhter R
    Adv Exp Med Biol; 2018; 1087():239-243. PubMed ID: 30259371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ANRIL, H19 and TUG1: a review about critical long non-coding RNAs in cardiovascular diseases.
    da Cunha Agostini L; Almeida TC; da Silva GN
    Mol Biol Rep; 2023 Dec; 51(1):31. PubMed ID: 38155319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The correlation of serum long non-coding RNA ANRIL with risk factors, functional outcome, and prognosis in atrial fibrillation patients with ischemic stroke.
    Zeng W; Jin J
    J Clin Lab Anal; 2020 Aug; 34(8):e23352. PubMed ID: 32358844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ANRIL polymorphisms in psoriasis vulgaris patients in northern China.
    Hao S; Zhou K; Yu P; Tian J; Zhang Y; Dang L; Tong N; Li Y
    Eur J Dermatol; 2022 Apr; 32(2):259-268. PubMed ID: 35866908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of long non‑coding RNA ANRIL promotes proliferation and migration in hypoxic human pulmonary artery smooth muscle cells.
    Wang S; Zhang C; Zhang X
    Mol Med Rep; 2020 Feb; 21(2):589-596. PubMed ID: 31974617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ANRIL: A Long Noncoding RNA in Age-related Diseases.
    Wang R; Yuan Q; Wen Y; Zhang Y; Hu Y; Wang S; Yuan C
    Mini Rev Med Chem; 2024; 24(21):1930-1939. PubMed ID: 38716553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long Noncoding RNA
    Holdt LM; Teupser D
    Front Cardiovasc Med; 2018; 5():145. PubMed ID: 30460243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging roles of long non-coding RNAs in the pathogenesis of Alzheimer's disease.
    Cortini F; Roma F; Villa C
    Ageing Res Rev; 2019 Mar; 50():19-26. PubMed ID: 30610928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA ANRIL impacts the progress of osteoarthritis via regulating proliferation and apoptosis of osteoarthritis synoviocytes.
    Li X; Huang TL; Zhang GD; Jiang JT; Guo PY
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9729-9737. PubMed ID: 31799639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A network based method for analysis of lncRNA-disease associations and prediction of lncRNAs implicated in diseases.
    Yang X; Gao L; Guo X; Shi X; Wu H; Song F; Wang B
    PLoS One; 2014; 9(1):e87797. PubMed ID: 24498199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of novel LncRNA P14AS as a protector of ANRIL through AUF1 binding in human cells.
    Ma W; Qiao J; Zhou J; Gu L; Deng D
    Mol Cancer; 2020 Feb; 19(1):42. PubMed ID: 32106863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-Coding RNA and Tumor Development in Neurofibromatosis Type 1:
    Tritto V; Ferrari L; Esposito S; Zuccotti P; Bianchessi D; Natacci F; Saletti V; Eoli M; Riva P
    Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31694342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reciprocal Regulation between lncRNA ANRIL and p15 in Steroid-Induced Glaucoma.
    Wan P; Huang S; Luo Y; Deng C; Zhou J; Long E; Zhuo Y
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of lncRNA ANRIL inhibits the development of cisplatin resistance by upregulating miR‑98 in lung cancer cells.
    Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M
    Oncol Rep; 2020 Sep; 44(3):1025-1036. PubMed ID: 32705261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA ANRIL and its target microRNAs (microRNA-34a, microRNA-125a and microRNA-186) relate to risk stratification and prognosis in multiple myeloma.
    Yin Y; Yang W; Zhang L; Liu K; Luo Z
    Hematology; 2021 Dec; 26(1):160-169. PubMed ID: 33528317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical significance of long non-coding RNA ANRIL level in diabetic retinopathy.
    Chen S; Zhong H; Wang Y; Wang Z; Liang X; Li S; Li Z; Yu Z; Li L; Yi G; Fu M
    Acta Diabetol; 2020 Apr; 57(4):409-418. PubMed ID: 31691869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.